DMB Acquisition Corp
Status: Stalled
U=S
| IPO Proceeds, $M | $75.00M |
|---|---|
| IPO Date | * |
| CEO | Andrew McDonald, Ph.D. |
| Left Lead | LifeSci Capital |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare |
| IPO Geography | US/Canada |
| Target Company | TBD |
| Deal Announced | TBD |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | TBD |
LSAC
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on DMB Acquisition Corp:
- Structure and cap table
- 7 directors & officers
- 4 filings and events
- 2 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Andrew McDonald, Ph.D. | 46 | Chairman, Chief Executive Officer and Director |
| Michael Rice | 55 | Chief Operating Officer and Director |
| David Dobkin | 41 | Chief Financial Officer and Director |
| Thomas Wynn | 51 | Director |
| Raquel Izumi, PhD | Director | |
| Adam Tomasi, PhD | Director | |
| Nassim Usman, PhD | 60 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| LifeSci Capital | Joint BR | 5,625,000 | units |
| Ladenburg Thalmann | Joint BR | 1,875,000 | |
| 7,500,000 | units | ||
| Up-Front UW fee | 1.00 | % | |
| BCMA | 3.50 | % |
Sign in to view more advisor data.
Filings
Sign in to view 4 filings.